click below
click below
Normal Size Small Size show me how
Platelets (Hema2)
Cards for Medical technology students currently taking Hema2 on Platelets
Question | Answer |
---|---|
Predisposition to thrombosis secondary to a congenital or acquired disorder | thrombophilia |
A clot that breaks free and begins to travel around the body is known as | embolus |
formation of a thrombus (blood clot) within a vein. | Venous thrombosis |
blockage of the main artery of the lung or one of its branches by a substance that has travelled from elsewhere in the body through the bloodstream | Pulmonary embolism |
most commonly results from deep vein thrombosis that breaks off and migrates to the lung | venous thromboembolism |
formation of a thrombus within an artery. In most cases, arterial thrombosis follows rupture of atheroma, and is therefore referred to as | atherothrombosis. |
causes a blood stasis within the atria with easy thrombus formation. | atrial fibrillation |
Factors that Affect Evaluation | Anticoagulant therapy Recent thrombotic events Testing for AT, PS, PC, Factor VIII, and LA must be performed 10 to 14 days after therapy |
Family of Ab that bind protein-phospholipid complexes Include: | Lupus anticoagulant (clot-based assay) ➢ Anticardiolipin (immunoassay) ➢ Anti-β2GPI (immunoassay |
an immune response to nonself antigens from members of the same species, which are called alloantigens or isoantigens | Alloimmune |
happens when the body's natural defense system can't tell the difference between your own cells and foreign cells, causing the body to mistakenly attack normal cells | Autoimmune |
PTT with low reagent phospholipid | Factor XII |
DRVVT (Dilute Russell viper venom time) | Factor X |
KCT (Kaolin Clotting Time) | Factor XII |
DTT (Dilute Thromboplastin Time) | Factor VII |
Mutation Cause for increased thrombosis Assay | Prothrombin G20210A |
risk factor for arterial thrombosis | Plasma Homocysteine |
Homozygosity for the MTHFR C677T mutation is associated with ______________but is not an independent thrombosis risk factor. | Homocysteinemia |
The plasma is first treated with a reducing agent to convert all disulfide forms to homocysteine, which becomes bound to fluorescein to form a detectable fluorescent derivative (not standardized) | High-performance liquid chromatography |
plasma disulfides are reduced, the homocysteine is converted to S-adenosylhomocysteine, and the S-adenosylhomocysteine is bound to an antibody conjugated to a fluorescein tracer. | Enzyme immunoassay |
TRUE OR FALSE. Plasma homocysteine rises by 10% per hour if blood is kept intact at room temperature after collection. | TRUE |
Plasma collection may be accomplished using | heparin, sodium citrate, or ethylenediaminetetraacetic acid (EDTA) anticoagulants. |
is a quantitative, clot-based, functional assay. The assay measures the ability of fibrinogen to form fibrin clot after being exposed to a high concentration of purified thrombin. | Clot based method for Clauss |
High fibrinogen concentration predicts | hypercholesterolemia |
Makes blood more viscous (favors coagulation, plt activation, and formation of atherothrombotic lesions) | Fibrinogen activity |
s a rare and serious condition that disrupts your blood flow. It is a blood clotting disorder that can turn into uncontrollable bleeding. | Disseminated intravascular coagulation (DIC) |
is the primary culprit of DIC because it activates platelets, activates coagulation proteins, and catalyzes fibrin formation, of which the ensuing clots consume control proteins. | Circulating thrombin |
In DIC, Thrombin cleaves fibrinogen, creating ________. | Fibrin monomers |
Free plasmin digests ... | V, VIII, IX, and XI |
is seen in meningococcemia, chickenpox, and spirochete infections. | Purpura fulminans |
____ and ________ immunoassays are sensitive and specific for thrombosis, which occurs in DIC, septicemia, eclampsia, pancreatitis, leukemia, liver disease, and trauma. | Thrombin-Antithrombin (TAT) Prothrombin fragment 1 + 2 (PF 1+2) |
Adverse effect of treatment with unfractionated heparin | eparin induced thrombocytopenia with thrombosis (HIT) |